Hub : Traits :

Body Mass Index (BMI) (2010)

310 significantly associated models · 46 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	71163715	73435171	1	1	1.3e-13	1.2e-14	1.8e-03	84	NEGR1
2	2	24348096	25837917	1	1	1.3e-07	1.8e-07	3.6e-01	97	ADCY3
3	3	140514022	142017527	1	1	3.0e-07	1.1e-06	6.3e-02	85	RASA2
4	3	185520342	186072370	1	1	2.2e-12	1.3e-12	2.2e-02	90	ETV5
5	11	46570859	48485877	11	1	2.5e-11	4.8e-11	1.0e+00	100	C1QTNF4
6	12	49569311	50991370	1	1	2.2e-08	4.0e-11	1.3e-04	67	FAIM2
7	13	27315078	28717392	1	1	1.3e-07	3.0e-07	5.6e-02	86	MTIF3
8	15	67138238	68789191	1	1	2.6e-11	1.2e-10	1.3e-01	94	MAP2K5
9	16	19022448	20596558	5	1	9.8e-11	4.6e-11	1.0e+00	100	GPRC5B
10	16	27655848	29595483	19	1	3.1e-13	1.7e-10	2.4e-01	97	EIF3CL
11	16	52828325	54846383	2	2	1.0e-17	3.1e-62	7.9e-37	42	AKTIP FTO
12	18	57349900	58729694	1	1	2.6e-07	2.1e-22	1.1e-16	28	MC4R
13	19	34044119	34553925	1	1	2.3e-07	2.4e-09	1.0e+00	100	KCTD15

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Depressed Affect (Nagel 2018)	2.50	1	1	2.2	0.00	1.0e+00	C1QTNF4
Intelligence (Savage-Jansen 2018)	6.79	3	2	4.4	0.00	1.0e+00	C1QTNF4 EIF3CL NEGR1
Neuroticism (Nagel 2018)	3.03	2	1	2.2	0.00	1.0e+00	C1QTNF4 MC4R
Worry (Nagel 2018)	3.44	2	2	4.4	0.00	1.0e+00	C1QTNF4 MC4R
Crohns Disease (2017)	3.84	2	2	4.4	0.00	1.0e+00	ADCY3 EIF3CL
Irritable Bowel Disease (IBD)	3.55	2	2	4.4	0.00	1.0e+00	ADCY3 EIF3CL
Ulcerative Colitis (UC)	1.70	1	0	0.0	0.00	1.0e+00	EIF3CL
Major Depression (MDD)	3.63	1	1	2.2	0.00	1.0e+00	NEGR1
Reaction Time	1.01	1	0	0.0	0.00	1.0e+00	ADCY3
Verbal and Numeric Reasoning (VNR)	5.88	4	2	4.4	-0.05	9.5e-01	ADCY3 C1QTNF4 EIF3CL NEGR1
Breast Cancer	4.09	3	1	2.2	0.00	1.0e+00	ADCY3 AKTIP FTO
Crohns Disease (2012)	3.93	2	1	2.2	0.00	1.0e+00	ADCY3 EIF3CL
HDL Cholesterol	3.73	1	0	0.0	0.00	1.0e+00	C1QTNF4
Neuroticism (2016)	2.41	1	0	0.0	0.00	1.0e+00	C1QTNF4
Type 2 Diabetes (T2D) (2012)	3.56	1	0	0.0	0.00	1.0e+00	MC4R
Blood Eosinophil Count	0.74	1	0	0.0	0.00	1.0e+00	ADCY3
Blood Platelet Count	1.31	2	2	4.4	0.00	1.0e+00	C1QTNF4 GPRC5B
Blood Red Count	1.31	3	2	4.4	0.00	1.0e+00	EIF3CL ETV5 RASA2
Blood White Count	1.68	3	1	2.2	0.00	1.0e+00	ADCY3 C1QTNF4 MAP2K5
Heel T-Score	0.93	3	2	4.4	0.00	1.0e+00	FAIM2 GPRC5B NEGR1
BMI	28.35	14	14	31.1	0.96	3.7e-08	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Height	3.04	5	4	8.9	-0.38	5.3e-01	ADCY3 C1QTNF4 GPRC5B MC4R MTIF3
Waist Hip Ratio (WHR)	0.85	1	0	0.0	0.00	1.0e+00	FTO
Systolic Blood Pressure	2.70	2	2	4.4	0.00	1.0e+00	ADCY3 C1QTNF4
Smoking Status	1.82	1	0	0.0	0.00	1.0e+00	ADCY3
Allergy or Eczema	1.78	2	1	2.2	0.00	1.0e+00	EIF3CL NEGR1
Cardiovascular Disease	2.33	2	1	2.2	0.00	1.0e+00	FTO NEGR1
Type 2 Diabetes (T2D) (2018)	4.10	2	0	0.0	0.00	1.0e+00	AKTIP C1QTNF4
Lung FEV1/FVC ratio	1.64	2	2	4.4	0.00	1.0e+00	ADCY3 NEGR1
Lung FVC	1.33	2	1	2.2	0.00	1.0e+00	EIF3CL MAP2K5
Neuroticism	2.98	3	1	2.2	0.00	1.0e+00	C1QTNF4 MAP2K5 MC4R
Chronotype (morning person)	3.24	4	1	2.2	0.69	3.1e-01	ADCY3 AKTIP C1QTNF4 FTO
Hair Pigment	0.15	1	0	0.0	0.00	1.0e+00	ADCY3
Tanning	0.44	2	1	2.2	0.00	1.0e+00	ADCY3 C1QTNF4
Hand grip strength (left)	4.39	3	2	4.4	0.00	1.0e+00	ADCY3 C1QTNF4 GPRC5B
Number of treatments/medications taken	1.59	1	0	0.0	0.00	1.0e+00	NEGR1
Frequency of depressed mood in last 2 weeks	1.85	1	0	0.0	0.00	1.0e+00	C1QTNF4
Medication: Metformin	4.08	1	0	0.0	0.00	1.0e+00	C1QTNF4
Pack years adult smoking proportion	1.64	1	0	0.0	0.00	1.0e+00	EIF3CL
Impedance of leg (right)	13.91	13	10	22.2	-0.94	1.4e-06	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1 RASA2
Leg fat-free mass (left)	13.41	11	11	24.4	0.95	5.2e-06	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Trunk fat percentage	14.98	11	9	20.0	0.93	2.6e-05	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R MTIF3 NEGR1
Hand grip strength (right)	3.59	4	2	4.4	-0.74	2.6e-01	ADCY3 C1QTNF4 EIF3CL GPRC5B
Townsend deprivation index at recruitment	2.77	1	0	0.0	0.00	1.0e+00	MAP2K5
Current tobacco smoking	2.28	1	0	0.0	0.00	1.0e+00	C1QTNF4
Taking other prescription medications	1.64	1	0	0.0	0.00	1.0e+00	NEGR1
Age when periods started (menarche)	9.22	9	5	11.1	-0.99	9.6e-07	ADCY3 AKTIP C1QTNF4 ETV5 FAIM2 FTO GPRC5B MAP2K5 NEGR1
High blood pressure	1.95	1	0	0.0	0.00	1.0e+00	NEGR1
Hayfever, allergic rhinitis or eczema	1.36	1	0	0.0	0.00	1.0e+00	NEGR1
Multivitamins +/- minerals	2.39	1	0	0.0	0.00	1.0e+00	NEGR1
Sitting height	3.68	3	2	4.4	0.00	1.0e+00	ADCY3 C1QTNF4 MTIF3
Body mass index (BMI)	22.95	14	11	24.4	0.96	4.7e-08	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Impedance of leg (left)	13.79	13	9	20.0	-0.93	3.0e-06	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Leg predicted mass (left)	13.39	11	11	24.4	0.95	5.3e-06	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Trunk fat mass	16.52	13	11	24.4	0.95	5.2e-07	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Waist circumference	18.78	13	11	24.4	0.97	9.6e-08	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Past tobacco smoking	3.08	2	0	0.0	0.00	1.0e+00	ADCY3 MAP2K5
Alcohol usually taken with meals	2.91	2	0	0.0	0.00	1.0e+00	EIF3CL NEGR1
Forced vital capacity (FVC)	2.59	2	2	4.4	0.00	1.0e+00	ADCY3 C1QTNF4
Qualifications: None of the above	3.04	2	2	4.4	0.00	1.0e+00	EIF3CL NEGR1
Allergy	0.98	1	0	0.0	0.00	1.0e+00	NEGR1
Fluid intelligence score	5.01	3	2	4.4	0.00	1.0e+00	C1QTNF4 EIF3CL NEGR1
Neuroticism score	2.91	2	1	2.2	0.00	1.0e+00	C1QTNF4 MC4R
Weight	16.77	14	13	28.9	0.95	1.1e-07	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Impedance of arm (right)	8.25	9	7	15.6	-0.96	3.4e-05	AKTIP ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1
Arm fat percentage (right)	21.14	13	11	24.4	0.94	2.4e-06	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Trunk fat-free mass	8.28	11	8	17.8	0.82	2.2e-03	AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MC4R MTIF3 NEGR1
Hip circumference	17.78	14	12	26.7	0.95	1.3e-07	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Alcohol intake versus 10 years previously	2.02	1	0	0.0	0.00	1.0e+00	NEGR1
Worrier / anxious feelings	2.48	1	0	0.0	0.00	1.0e+00	MC4R
Forced expiratory volume in 1-second (FEV1)	1.90	2	1	2.2	0.00	1.0e+00	ADCY3 C1QTNF4
Qualifications: A levels/AS levels or equivalent	1.84	2	1	2.2	0.00	1.0e+00	EIF3CL NEGR1
Serious illness, injury or assault of a close relative in last 2 years	1.94	1	0	0.0	0.00	1.0e+00	EIF3CL
Forced expiratory volume in 1-second (FEV1), Best measure	1.71	2	2	4.4	0.00	1.0e+00	ADCY3 C1QTNF4
Impedance of arm (left)	8.47	9	6	13.3	-0.95	6.9e-05	AKTIP ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1
Arm fat mass (right)	21.32	14	12	26.7	0.96	6.1e-08	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Trunk predicted mass	8.31	11	7	15.6	0.82	2.1e-03	AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MC4R MTIF3 NEGR1
Standing height	3.34	4	3	6.7	-0.17	8.3e-01	ADCY3 C1QTNF4 EIF3CL MC4R
Seen doctor (GP) for nerves, anxiety, tension or depression	4.77	2	1	2.2	0.00	1.0e+00	MAP2K5 NEGR1
Birth weight of first child	1.57	1	0	0.0	0.00	1.0e+00	EIF3CL
Peak expiratory flow (PEF)	1.31	2	0	0.0	0.00	1.0e+00	ADCY3 C1QTNF4
Medication for cholesterol, blood pressure or diabetes	2.61	1	0	0.0	0.00	1.0e+00	AKTIP
Birth weight	2.25	1	0	0.0	0.00	1.0e+00	C1QTNF4
Forced vital capacity (FVC), Best measure	2.51	2	2	4.4	0.00	1.0e+00	ADCY3 C1QTNF4
Body fat percentage	16.66	11	9	20.0	0.94	1.8e-05	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R MTIF3 NEGR1
Leg fat percentage (right)	15.01	11	9	20.0	0.94	1.9e-05	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R NEGR1 RASA2
Arm fat-free mass (right)	9.88	11	10	22.2	0.94	1.4e-05	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Comparative body size at age 10	45.14	12	11	24.4	0.92	1.8e-05	ADCY3 AKTIP C1QTNF4 EIF3CL FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Qualifications: College or University degree	4.18	3	2	4.4	0.00	1.0e+00	EIF3CL ETV5 NEGR1
Whole body fat mass	18.50	13	12	26.7	0.96	1.8e-07	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Leg fat mass (right)	19.55	14	11	24.4	0.96	7.2e-08	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Arm predicted mass (right)	9.94	11	10	22.2	0.94	1.2e-05	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Pulse rate, automated reading	1.63	2	1	2.2	0.00	1.0e+00	GPRC5B NEGR1
Alcohol intake frequency.	6.41	3	2	4.4	0.00	1.0e+00	C1QTNF4 EIF3CL NEGR1
Comparative height size at age 10	3.13	6	3	6.7	0.39	4.5e-01	ADCY3 C1QTNF4 EIF3CL FAIM2 FTO MTIF3
Suffer from 'nerves'	6.21	3	3	6.7	0.00	1.0e+00	C1QTNF4 EIF3CL MC4R
Commuting to job workplace: Car/motor vehicle	2.24	1	0	0.0	0.00	1.0e+00	NEGR1
Hypertension (Self-reported)	1.78	1	0	0.0	0.00	1.0e+00	NEGR1
Forced expiratory volume in 1-second (FEV1), predicted	2.50	2	0	0.0	0.00	1.0e+00	ADCY3 C1QTNF4
Whole body fat-free mass	10.31	11	10	22.2	0.94	1.5e-05	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Leg fat-free mass (right)	12.69	11	11	24.4	0.96	4.3e-06	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Arm fat percentage (left)	21.64	13	11	24.4	0.94	2.3e-06	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Handedness (chirality/laterality): Left-handed	2.91	1	0	0.0	0.00	1.0e+00	EIF3CL
Mood swings	1.56	1	0	0.0	0.00	1.0e+00	C1QTNF4
Loneliness, isolation	2.54	1	1	2.2	0.00	1.0e+00	C1QTNF4
Long-standing illness, disability or infirmity	2.70	1	0	0.0	0.00	1.0e+00	NEGR1
Diabetes diagnosed by doctor	2.88	1	0	0.0	0.00	1.0e+00	AKTIP
Qualifications: nursing, teaching	2.67	1	1	2.2	0.00	1.0e+00	NEGR1
Breast cancer (self-reported)	1.60	1	0	0.0	0.00	1.0e+00	FTO
Smoking status: Current	2.13	1	0	0.0	0.00	1.0e+00	C1QTNF4
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.12	1	0	0.0	0.00	1.0e+00	EIF3CL
Whole body water mass	10.33	11	10	22.2	0.94	1.5e-05	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Leg predicted mass (right)	12.77	11	10	22.2	0.96	4.6e-06	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Arm fat mass (left)	21.76	14	12	26.7	0.96	5.6e-08	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Number of self-reported non-cancer illnesses	2.34	1	1	2.2	0.00	1.0e+00	NEGR1
Miserableness	2.53	1	1	2.2	0.00	1.0e+00	C1QTNF4
Guilty feelings	2.98	1	0	0.0	0.00	1.0e+00	C1QTNF4
Hearing aid user	2.99	1	0	0.0	0.00	1.0e+00	ADCY3
Commuting to job workplace: Public transport	2.14	1	0	0.0	0.00	1.0e+00	NEGR1
Basal metabolic rate	11.86	12	10	22.2	0.95	3.3e-06	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Leg fat percentage (left)	15.77	11	9	20.0	0.95	8.5e-06	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R NEGR1 RASA2
Arm fat-free mass (left)	10.72	11	10	22.2	0.94	1.4e-05	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Number of operations (self-reported)	1.43	1	0	0.0	0.00	1.0e+00	NEGR1
Average weekly beer plus cider intake	4.27	1	0	0.0	0.00	1.0e+00	NEGR1
Diastolic blood pressure, automated reading	1.46	1	0	0.0	0.00	1.0e+00	MAP2K5
Vascular/heart problems diagnosed by doctor	1.71	2	0	0.0	0.00	1.0e+00	MAP2K5 NEGR1
Impedance of whole body	12.29	11	9	20.0	-0.95	8.6e-06	ADCY3 AKTIP ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1 RASA2
Leg fat mass (left)	19.81	14	11	24.4	0.96	5.3e-08	ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Arm predicted mass (left)	10.43	11	10	22.2	0.94	1.3e-05	AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	11	0.325	1.5
GTEx	Adipose Visceral Omentum	4	0.203	1.5
GTEx	Adrenal Gland	2	0.141	1.3
GTEx	Artery Aorta	10	0.348	1.5
GTEx	Artery Coronary	2	0.173	1.5
GTEx	Artery Tibial	10	0.275	1.5
GTEx	Brain Caudate basal ganglia	2	0.224	1.5
GTEx	Brain Cerebellar Hemisphere	1	0.069	1.6
GTEx	Brain Cerebellum	1	0.052	1.6
GTEx	Brain Cortex	4	0.399	1.6
GTEx	Brain Frontal Cortex BA9	1	0.112	1.5
GTEx	Brain Hippocampus	1	0.197	1.3
GTEx	Brain Hypothalamus	1	0.175	1.5
GTEx	Brain Nucleus accumbens basal ganglia	2	0.237	1.5
GTEx	Brain Putamen basal ganglia	1	0.165	1.5
GTEx	Breast Mammary Tissue	8	0.419	1.5
GTEx	Breast Mammary Tissue (Male)	4	0.345	1.4
GTEx	Breast Mammary Tissue (Female)	4	0.254	1.4
GTEx	Cells EBV-transformed lymphocytes	1	0.073	1.5
GTEx	Cells Transformed fibroblasts	8	0.196	1.5
GTEx	Colon Sigmoid	4	0.281	1.4
GTEx	Colon Transverse	6	0.302	1.5
GTEx	Esophagus Gastroesophageal Junction	4	0.286	1.5
GTEx	Esophagus Mucosa	5	0.155	1.5
GTEx	Esophagus Muscularis	10	0.319	1.5
GTEx	Heart Atrial Appendage	4	0.261	1.5
GTEx	Heart Left Ventricle	6	0.406	1.6
GTEx	Liver	3	0.430	1.6
GTEx	Lung	6	0.216	1.5
GTEx	Muscle Skeletal	6	0.214	1.5
GTEx	Nerve Tibial	9	0.215	1.5
GTEx	Ovary	5	0.567	1.6
GTEx	Pancreas	3	0.189	1.5
GTEx	Pituitary	2	0.183	1.5
GTEx	Prostate	2	0.248	1.4
GTEx	Skin Not Sun Exposed Suprapubic	8	0.334	1.5
GTEx	Skin Sun Exposed Lower leg	9	0.255	1.5
GTEx	Small Intestine Terminal Ileum	1	0.222	1.5
GTEx	Spleen	5	0.363	1.6
GTEx	Stomach	5	0.353	1.6
GTEx	Testis	10	0.327	1.5
GTEx	Thyroid	3	0.078	1.4
GTEx	Uterus	1	0.181	1.4
GTEx	Vagina	5	0.814	1.7
GTEx	Whole Blood	7	0.365	1.6
METSIM	Adipose	8	0.177	1.4
NTR	Blood	2	0.084	1.3
ROSMAP	Brain Pre-frontal Cortex	6	0.141	1.5
YFS	Blood	3	0.066	1.3
CommonMind	Brain Pre-frontal Cortex	8	0.152	1.3
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	4	0.259	1.4
The Cancer Genome Atlas	Breast Invasive Carcinoma	6	0.145	1.3
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	2	0.192	1.5
The Cancer Genome Atlas	Colon Adenocarcinoma	4	0.208	1.4
The Cancer Genome Atlas	Esophageal Carcinoma	1	0.154	1.4
The Cancer Genome Atlas	Glioblastoma Multiforme	1	0.104	1.4
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	6	0.234	1.4
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	6	0.155	1.3
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	5	0.259	1.4
The Cancer Genome Atlas	Brain Lower Grade Glioma	5	0.123	1.4
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	4	0.384	1.4
The Cancer Genome Atlas	Lung Adenocarcinoma	5	0.181	1.3
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	4	0.170	1.4
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	3	0.201	1.4
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	2	0.127	1.3
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	2	0.160	1.3
The Cancer Genome Atlas	Prostate Adenocarcinoma	4	0.092	1.3
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.2
The Cancer Genome Atlas	Soft Tissue Sarcoma	1	0.101	1.3
The Cancer Genome Atlas	Skin Cutaneous Melanoma	2	0.405	1.3
The Cancer Genome Atlas	Stomach Adenocarcinoma	3	0.189	1.4
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.3
The Cancer Genome Atlas	Thyroid Carcinoma	5	0.102	1.3
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	1	0.208	1.3